T cells and NKT cells in the pathogenesis of asthma

Annual Review of Medicine

Volumn 59, Issue , 2008, Pages 281-292

  Meyer, Everett H ^a   DeKruyff, Rosemarie H ^b   Umetsu, Dale T ^b  

^a STANFORD UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Airway hyperreactivity; Allergy

Indexed keywords

ALLERGEN; BETA 2 MICROGLOBULIN; CD1D ANTIGEN; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ANTIGEN RECOGNITION; ASTHMA; ATOPY; B LYMPHOCYTE; BODY PLETHYSMOGRAPHY; BORRELIA BURGDORFERI; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EOSINOPHILIA; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOSURVEILLANCE; MAST CELL; MOUSE; NATURAL KILLER T CELL; NEUTROPHILIA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RICKETTSIA; SPHINGOMONAS PAUCIMOBILIS; T LYMPHOCYTE; TH2 CELL; WILD TYPE;

ASTHMA; CELL COMMUNICATION; HUMANS; KILLER CELLS, NATURAL; TH2 CELLS;

EID: 39649120347     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.59.061506.154139     Document Type: Review

References (56)

1. Mannino DM, Homa DM, Akinbami LJ, et al. 2002. Surveillance for asthma - United States, 1980-1999. Morb. Mortal. Wkly. Rep. CDC Surveill. Summ. 51:1-13
2. Umetsu DT, McIntire JJ, Akbari O, et al. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:715-20
3. Busse WW, Lemanske RF. 2001. Advances in immunology: asthma. N. Engl. J. Med. 344:350-62
4. Brusasco V, Crimi E, Pellegrino R. 1998. Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 53:992-98
5. Kiley J, Smith R, Noel P. 2007. Asthma phenotypes. Curr. Opin. Pulm. Med. 13:19-23
6. Martinez FD. 2003. Toward asthma prevention - Does all that really matters happen before we learn to read? N. Engl. J. Med. 349:1473-75
7. Sears MR, Greene JM, Willan AR, et al. 2003. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N. Engl. J. Med. 349:1414-22
8. Galli SJ. 1997. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186:343-47
9. Rossi GL, Olivieri D. 1997. Does the mast cell still have a key role in asthma? Chest 112:523-29
10. Wills-Karp M. 1999. Immunological basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-81
11. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell Mol. Biol. 10:587-93
12. Robinson DS, Hamid Q, Ying S, et al. 1992. Predominant Th2-like bronchoalveolar lymphocyte-T population in atopic asthma. N. Engl. J. Med. 326:298-304
13. Mosmann TR, Cherwinski H, Bond MW, et al. 2005. Pillars article: two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 175:5-14
14. Umetsu DT, DeKruyff RH. 2006. Immune dysregulation in asthma. Curr. Opin. Immunol. 18:727-32
15. Taniguchi M, Seino K, Nakayama T. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164-65
16. Kronenberg M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877-900
17. + T cells to dexamethasone. J. Immunol. 163:2522-29
18. Umetsu DT, DeKruyff RH. 2006. Opinion - a role for natural killer T cells in asthma. Nat. Rev. Immunol. 6:953-58
19. Godfrey DI, MacDonald HR, Kronenberg M, et al. 2004. Opinion - NKT cells: What's in a name? Nat. Rev. Immunol. 4:231-37
20. Lisbonne M, Diem S, Keller AD, et al. 2003. Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:1637-41
21. Akbari O, Stock P, Meyer E, et al. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582-88
22. Kim CH, Butcher EC, Johnston B. 2002. Distinct subsets of human V alpha 24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23:516-19
23. Gumperz JE, Miyake S, Yamamura T, et al. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625-36
24. Crowe NY, Coquet JM, Berzins SP, et al. 2005. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202:1279-88
25. Michel ML, Keller A, Paget C, et al. 2007. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204:995-1001
26. Bendelac A, Savage P, Teyton L. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336
27. Zhou DP, Mattner J, Cantu C, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786-89
28. Mattner J, DeBord KL, Ismail N, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-29
29. Kinjo Y, Wu D, Kim GS, et al. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-25
30. Kinjo Y, Tupin E, Wu D, et al. 2006. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7:978-86
31. Stein-Streilein J. 2003. Invariant NKT cells as initiators, licensors, and facilitators of the adaptive immune response. J. Exp. Med. 198:1779-83
32. Kaser A, Nieuwenhuis EES, Strober W, et al. 2004. Natural killer T cells in mucosal homeostasis. In Oral Tolerance: New Insights and Prospects for Clinical Application, ed. H Weiner, L Mayer, W Strober, pp. 154-68. New York: NY Acad. Sci.
33. Kim JO, Kim DH, Chang WS, et al. 2004. Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 114:1332-38
34. Matsuda H, Suda T, Sato J, et al. 2005. α-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell Mol. Biol. 33:22-31
35. Hachem P, Lisbonne M, Michel ML, et al. 2005. α-galactosylceramide- induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-γ. Eur. J. Immunol. 35:2793-802
36. Morishima Y, Ishii Y, Kimura T, et al. 2005. Suppression of eosinophilic airway inflammation by treatment with α-galactosylceramide. Eur. J. Immunol. 35:2803-14
37. + T cells. Proc. Natl. Acad. Sci. USA 103:2782-87
38. Agea E, Russano A, Bistoni O, et al. 2005. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202:295-308
39. Spinozzi F, Porcelli SA. 2007. Recognition of lipids from pollens by CD1-restricted T cells. Immunol. Allergy Clin. North Am. 27:79-92
40. Schnyder-Candrian S, Togbe D, Couillin I, et al. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203:2715-25
41. Barczyk A, Pierzcha W, Sozanska E. 2003. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir. Med. 97:726-33
42. Maeda M, Shadeo A, MacFadyen AM, et al. 2004. CD1d-independent NKT cells in β2 microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J. Immunol. 172:6115-22
43. Zhang Y, Rogers KH, Lewis DB. 1996. Beta-2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184:1507-12
44. + invariant T-cell-receptor plus natural killer T cells in bronchial asthma. N. Engl. J. Med. 354:1117-29
45. Pham-Thi N, de Blic J, Le Bourgeois M, et al. 2006. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J. Allergy Clin. Immunol. 117:217-18
46. Hamzaoui A, Rouhou SC, Grairi H, et al. 2006. NKT cells in the induced sputum of severe asthmatics. Mediat. Inflamm. 2006:1-6
47. Pham-Thi N, de Blic J, Leite-De-Moraes MC. 2006. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 354:2615
48. + T cells upon CD226 engagement. J. Immunol. 175:4914-26
49. Thomas SY, Lilly CM, Luster AD. 2006. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 354:2613-15
50. Vijayanand P, Seumois G, Pickard C, et al. 2007. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 356:1410-22
51. Brightling CE, Bradding P, Symon FA, et al. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-705
52. Ito K, Chung KF, Adcock IM. 2006. Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 117:522-43
53. Terabe M, Matsui S, Noben-Trauth N, et al. 2000. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1:515-20
54. Wang ZY, Kusam S, Munugalavadla V, et al. 2006. Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFKT2. J. Immunol. 176:880-88
55. National Institutes of Health. 2007. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH Publ. No. 07-4051. Bethesda, MD: Natl. Inst. Health
56. Abraham B, Anto JM, Barreiro E, et al. 2003. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur. Respir. J. 22:470-77